LINK: https://arizona.zoom.us/j/85407834493?pwd=ZGh2anBuckNYWmhobTVFQXdVY2pZUT09
Zoom PW: 843961
Dr. Hani Jneid – Associate Professor of Medicine, Baylor College of Medicine as the SHC Grand Rounds Speaker, Friday, May 28.
DATE: 5/28/21
TIME: 12:00 – 1:00 PM
TITLE: “AS and TAVR Updates: Insights from the 2020 ACC/AHA Guidelines”
LINK: https://arizona.zoom.us/j/85407834493?pwd=ZGh2anBuckNYWmhobTVFQXdVY2pZUT09
Zoom PW: 843961
CME code will be provided tomorrow. There were issues with the website.
Hani Jneid, MD, FACC, FAHA
I am an Associate Professor of Medicine at Baylor College of Medicine, where I also serve also as the Director of Interventional Cardiology Fellowship Program and the Director of Interventional Cardiology Research in Houston, TX. I also serve as the Director of Interventional Cardiology at its affiliate, the Michael E. DeBakey VA Medical Center.
I have obtained ABIM-board certification in the 3 specialties of Internal Medicine, Cardiovascular Medicine, and Interventional Cardiology. I have also held certification by the American Society of Nuclear Cardiology (ASNC) and the American Society of Cardiovascular Computed Tomography (SCCT). I am a high-volume interventional cardiologist with expertise in coronary and structural heart intervention/TAVR procedures. I actively care for patients in the coronary care unit and clinic, in addition to performing a large number of invasive cardiac procedures (~ 500) in the cardiac cath lab, including complex coronary interventions, ventricular assist devices, and transcatheter heart valve procedures. I was a member of the team that initiated the transcatheter aortic valve in the whole VA healthcare system; I have been one of the largest volume interventional operators in the VA healthcare system for several years; and I am currently leading the efforts to open a new TAVR program at one of Baylor training sites.
I am a fellow of the Council on Clinical Cardiology of the American Heart Association (FAHA), a fellow of American College of Cardiology (FACC), and a fellow of the Society for Cardiovascular Angiography and Interventions (FSCAI). I serve as a Senior Associate editor for JAHA, I am on the Editorial Board of JACC, AJC, and several other journals, and I also serve as a reviewer for several journals.
I am currently engaged in research activities in the areas of interventional cardiology, acute coronary syndromes, stable ischemic heart disease, transcatheter heart valves, and quality of care and outcomes research. I have numerous publications (253 peer-reviewed publications to date), including in leading medical journals such as the New England Journal of Medicine, Lancet, Circulation, the Journal of the American College of Cardiology, CCI and AJM. I have led a large research team composed of 2 full-team research nurses and , and participated in multicenter VA cooperative multisite clinical trials (PRESERVE, DIVA, CLOP), with total enrollment of more than 6,000 patients.
I have participated in numerous national and international scientific forums as a presenter, panel discussant, and/or a moderator including the annual sessions of the AHA, ACC, ESC, SCAI, and CRT. I am the recipient of the first Get with the Guidelines database seed grant from the Council on Clinical Cardiology of the AHA. I currently conduct multiple database research projects and meta-analyses using local and national clinical databases, and I am the site investigator for numerous clinical trials, including the VA cooperative studies DIVA, PRESERVE and ADHERENCE. My previous research interest was in the field of adult cardiac stem cell therapy, and I was one of the leading members of a research group who worked with members of the Center for Biologics Evaluation & Research at the FDA to initiate the first FDA-approved human trial administering cardiac stem cells in patients with chronic myocardial infarction.
I have received numerous awards including the Senior Medical Resident of the Year Award at the Cleveland Clinic (2002), the Fellow of the Year Award at the University of Louisville (2004), the Second Prize in Clinical Research from the Massachusetts Medical Society (2007), the Young Leadership Recognition Program Award at the Cardiovascular Research Technologies (CRT) Forum (2010), the Fulbright & Jaworski L.L.P. Faculty Excellence Award for Teaching (2013), the Fulbright & Jaworski L.L.P. Faculty Excellence Award for Development of Enduring Educational Materials (2013), the Rising Star Clinician Award at Baylor College of Medicine (2014), 2018 ACC Emerging Faculty, 2019 WHF emerging faculty, the 2021 ACC Gifted Educator Award, and the Clinician Star Award at Baylor (2021).
I lecture annually at Baylor Medical School and I am actively involved in teaching medical students, residents, and cardiology fellows at the bedside and in the cardiac catheterization laboratory, and mentoring trainees in clinical and interventional cardiology locally. I have served as a mentor of the American Heart Association, and coordinated for some time the International Mentoring Program for the Council on Clinical Cardiology of the American Heart Association. I have also served as a member of several national committees, including the AHA Interventional Cardiology Subcommittee, the AHA Leadership Committee of the Council on Clinical Cardiology, the AHA Leadership Committee of the Council on Quality of Care and Outcomes Research (QCOR), the AHA/ACC Task Force for Data Standards (currently vice chair), the national AHA Executive Database Steering Committee (EDSC), and the ACC Task Force for Performance Measures, and the Research and Publications Committee of the national Veterans Affairs Cardiovascular Assessment, Reporting and Tracking System.
In addition, I have served as a reviewer of several AHA Scientific Guidelines and Statements, and as a writing member on several AHA guidelines and position Statements. I have chaired the ACC/AHA 2012 Focused Updates of the UA/NSTEMI Guidelines, and served as a writing member of the 2013 Focused Update to the ACCF/AHA/SCAI 2007 clinical competence statement on cardiac interventional procedures, and the 2014 ACC/AHA Acute Coronary Syndromes Guideline, the 2017 ACC/AHA Valvular Heart Disease Guideline update, the 2020 AHA/ACC VHD Guideline, and the 2021 AHA/ACC Chest Pain guideline. I also participate in numerous AHA activities and endeavors in the past 15 years since I was a cardiology fellow.